SBI Healthcare Opportunities Fund · Regular · Growth
NAV
₹537.4864
as of 16 Nov 2026
Expense Ratio
1.98%
AUM
₹5,565 Cr
Lumpsum returns (CAGR)
- 1Y
- +23.84%
- 3Y
- +23.27%
- 5Y
- +19.04%
- Since Inception
- +15.71%
SIP returns (XIRR)
- 1Y
- +33.96%
- 3Y
- +19.99%
- 5Y
- +22.43%
- Since Inception
- +16.61%
What history actually did — last 10 years (Nov 2016 – Nov 2026)
A ₹5,000 monthly SIP for the last 10 years (Nov 2016 – Nov 2026)
Real NAV backtest
A ₹5,000 monthly SIP would be worth ₹16,89,021 today — ₹6,00,000 invested, 19.9% XIRR.
₹6,00,000
Invested
₹16,89,021
Value today
19.9%
XIRR (p.a.)
A ₹1,00,000 lumpsum, the last 10 years (Nov 2016 – Nov 2026)
Real NAV backtest
₹1,00,000 invested 10 years ago would be ₹3,95,775 today (14.8% CAGR).
A regular withdrawal plan (SWP)
Real NAV backtest
A ₹10,00,000 corpus withdrawing ₹5,000/month since Nov 2016 would still hold ₹22,68,730.
Fund vs Benchmark (TRI)
Same SIP, benchmark total-return index
The same SIP would be worth ₹16,89,021 in this fund vs ₹12,00,785 in the benchmark — outperformance of ₹4,88,236.
Buying the worst day
Real NAV backtest
₹1,00,000 invested on the worst market day of the last 10 years (Nov 2016 – Nov 2026) (22 Mar 2020) would be ₹5,22,944 today (5.23×).
Historical simulation using actual published NAVs for the stated period. Past performance may or may not be sustained in the future. Not investment advice.
Risk Metrics
Trailing 1 year, annualised0.96
Sharpe Ratio
+0.15
Alpha
0.61
Beta
0.98
Sortino
12.59%
Std Dev
-10.33%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 31 Oct 2026- Pharmaceuticals & Biotechnology61.75%
- Healthcare Services29.38%
- Chemicals & Petrochemicals4.39%
- Healthcare Equipment & Supplies1.53%
Each sector links to the mutual funds most exposed to it.
Thinking about SBI Healthcare Opportunities Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
- 1Sun Pharmaceutical Industries Ltd.10.55%
- 2Divi'S Laboratories Ltd.8.38%
- 3Max Healthcare Institute Ltd.4.96%
- 4Acutaas Chemicals Ltd.4.95%
- 5Apollo Hospitals Enterprise Ltd.4.87%
- 6Laurus Labs Ltd.4.76%
- 7Cipla Ltd.4.36%
- 8Torrent Pharmaceuticals Ltd.4.11%
- 9Aurobindo Pharma Ltd.3.10%
- 10Gland Pharma Ltd.3.06%
What this fund does
SBI Healthcare Opportunities Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
SBI Healthcare Opportunities Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by SBI Mutual Fund. The fund has been operational for over 27 years. It manages assets worth ₹5,565 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against BSE HEALTHCARE TRI. The current expense ratio is 1.98%.